Adenovirus Infection
📧 Sign up to get email alerts when something new happens for Adenovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]
This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid rece…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating haplo-identical viral-specific T cells to treat cytomegalovirus and adenovirus infections after hematopoie…
-
CLINICAL_TRIALS research · 2025-11-10Clinical Trial Update: Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone [Phase 3]
Phase 3 randomized trial evaluating adoptive family-matched cytotoxic T lymphocytes plus standard of care versus standard of care alone for …
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus [Phase 1, Phase 2]
This clinical trial update reports the completion of Phase 1/2 trials evaluating injections of CD4+ and CD8+ T cells targeting cytomegalovir…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating virus-specific T-lymphocytes to treat infections with adenovirus, cytomegalovirus, and Epstein-Barr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. [Phase 1]
Phase 1 clinical trial evaluating TETRAVI Multivirus CTLs to treat EBV, CMV, adenovirus, and BK virus infections in patients after allogenei…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection [Phase 2]
A Phase 2 clinical trial evaluating Adenovirus-specific cytotoxic T-lymphocytes for refractory Adenovirus infection in patients with primary…
-
CLINICAL_TRIALS other · 2025-08-05Clinical Trial Update: TETRAVI Expanded Access Program
This is an update on the TETRAVI Expanded Access Program sponsored by Baylor College of Medicine, covering viral infections including Epstei…
-
CLINICAL_TRIALS research · 2025-07-31Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections in Children and Young Adults [Phase 1]
Phase 1 trial evaluating R-MVST Cells for treatment of viral infections in children and young adults is currently recruiting, assessing safe…
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) [Phase 1]
This is a Phase 1 trial update reporting completion of a study evaluating allogeneic multivirus-directed cytotoxic T lymphocytes for Epstein…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Anti-viral T-cell Therapy by Gamma Capture [Phase 1, Phase 2]
Phase 1/2 clinical trial update of an anti-viral T-cell therapy using Gamma Capture for viral infections, currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory Adenovirus Infections [Phase 1, Phase 2]
This clinical trial update describes a pilot study of haploidentical donor-derived adenovirus-specific T-lymphocytes to treat refractory ade…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation [Phase 1, Phase 2]
This clinical trial update describes a Phase 1/2 study of antiviral cellular therapy intended to enhance T-cell reconstitution around hemato…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System® [Phase 2]
Phase 2 study evaluating the safety and feasibility of infusing donor-derived virus-specific T cells for post-transplant viral infections in…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation [EARLY_Phase 1]
Clinical trial update on an early-phase adoptive T cell therapy designed to treat adenovirus infection after allogeneic hematopoietic stem c…
-
CLINICAL_TRIALS other · 2024-12-30Clinical Trial Update: R-MVST Cells for Treatment of Viral Infections [Phase 1]
Phase 1 clinical trial evaluating R-MVST cells for the treatment of viral infections, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating donor-derived T lymphocytes for infections caused by adenovirus, cytomegalovirus, Epstein-Barr virus,…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection wi…
-
CLINICAL_TRIALS research · 2024-06-21Clinical Trial Update: A Phase 2a Study of IV BCV in Subjects With Adenovirus Infection [Phase 2]
A Phase 2a study of IV BCV for adenovirus infection is currently recruiting, with cytomegalovirus infection also listed among the conditions…
-
CLINICAL_TRIALS trial_result · 2024-05-16Clinical Trial Update: Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reports termination of a Phase 2/Phase 3 study of posoleucel (ALVR105, Viralym-M) for multi-virus prevention in patien…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: Posoleucel (ALVR105) for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation [Phase 3]
A Phase 3 trial evaluating posoleucel (ALVR105) for treating adenovirus infection after allogeneic hematopoietic cell transplantation was te…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant [Phase 2, Phase 3]
Clinical trial update reporting completed results for Posoleucel (ALVR105) studied to prevent multiple viral infections after allogeneic hem…
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Viral Specific T-Lymphocytes to Treat Adenovirus or CMV [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Viral Specific T-Lymphocytes for Adenovirus infection and Cytomegalovirus infection; the study is curren…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: Effectiveness of a Single Dose of Betamethasone in Children With Symptomatic Adenovirus Infection [Phase 3]
Phase 3 trial evaluating the effectiveness of a single dose of betamethasone in children with symptomatic adenovirus infection.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Study to Assess the Safety and Efficacy of Brincidofovir in Treatment of Early Versus Late Adenovirus Infection [Phase 3]
Phase 3 trial assessing brincidofovir for early versus late adenovirus infection has completed with results posted.